Research articlePublished 9 Feb 2026
Assessment of Extemporaneous Compounding of Dermatological Formulations in Governmental Hospital Pharmacies in Northwest Ethiopia: A Multicenter Descriptive Cross-Sectional Study
1Department of Pharmacy, College of Medicine and Health Sciences, Debre Markos University, Debre Markos, Ethiopia; 2Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 3Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 4Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Dermatological problems are among the leading causes of hospital visits in Ethiopia. Extemporaneous compounded products are currently used by many patients with different disorders. The aim of this study was to evaluate the most commonly prescribed extemporaneously compounded products and applicability of compounding guidelines at five randomly selected hospitals in Northwest Ethiopia. Methods: A hospital-based multicenter descriptive cross-sectional study was conducted by retrospectively analyzing prescription records for dermatological compounding from January to April 2023. A total of 423 prescriptions from hospital pharmacies were systematically selected. Data related to skin condition patterns, product selection, and dosage form types were extracted using a semi-structured data extraction tool and analyzed using SPSS version 25.0 at a significance level of 5%. Results: A total of 423 prescriptions containing dermatological products for compounding were analyzed. Most patients were female (82.1%) and aged 30-64 years (46.3%). Melasma (82.9%), acne vulgaris (68.6%), acute dermatitis (63.27%), and Rosacea (61.54%) were the top four dermatological diseases for which compounding preparations were prescribed. More than half of the prescriptions (56.26%) contained a combination of two drugs. The most common compounded dosage form was semisolid preparations (95.98%), while the remaining 17 (4.02%) being liquids. Salicylic acid (35.39%) was the most frequently prescribed active ingredient, followed by clobetasone (13.03%) and Betametasone (10.01%). Vaseline (47.62%) and Nivea cream (44.3%) were the most commonly used excipients for compound preparations. Hydroquinone (4%) with Nivea cream (30 gm) (17.0%), followed by salicylic acid (5%)+Betametasone (75 g)+Vaseline (20 g) (10.6%) were the most commonly prescribed dermatological formulations. Conclusion: Dermatological disease is more prevalent in the study area and extemporaneous compounding is a common element of pharmaceutical care. Extemporaneous and topical semisolid preparations containing two or more active ingredients are the most widely compounded and prescribed products. This study suggests the application of good manufacturing practices and compounding guidelines for extemporaneous compounding of dermatological formulations to ensure efficacy, quality, and safety.
Subjects
Public Health & EpidemiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOccupational Medicine & Health Affairs
- SubjectPublic Health & Epidemiology
- BylineArticles whose byline prints “Ephrem Mebratu Dagnew”
- BylineArticles whose byline prints “Ashenafi Kibert Sendkie”
- BylineArticles whose byline prints “Wondale Tsega”
- BylineArticles whose byline prints “Biset Asrade Mekonnen”
- BylineArticles whose byline prints “Melese Getachew”